Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo

PHASE2CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Nocturia
Interventions
DRUG

Desmopressin

Desmopressin oral lyophilisate melt tablet, in either the 10, 25, 50, or 100 μg dosage, for sublingual administration

DRUG

Placebo

Placebo melt tablet for sublingual administration

Trial Locations (36)

Unknown

Japanese Red Cross Nagoya Daiichi Hospital, Nagoya

National Center for Geriatrics and Gerontology, Ōbu

Kokuho Asahi Central Hospital, Asahi

University of Fukui Hospital, Yoshida

Takayama Hospital, Chikushino-shi

Harasanshin Hospital, Fukuoka

Saku Hospital, Fukuoka

Southwest Urological Clinic, Fukuoka

Yakuin Urogenital Hospital, Fukuoka

Houshikai Group Kano Hospital, Koga

St. Mary's Hospital, Kurume

Fukushima Red Cross Hospital, Fukushima

Ohara General Hospital, Fukushima

Saiseikai Fukushima General Hospital, Fukushima

Jyusendo General Hospital, Kōriyama

Social Insurance Nihonmatsu Hospital, Nihommatsu

Takayama Clinic, Awagi

National Hospital Organization Kobe Medical Center, Kobe

Japanese Red Cross Mito Hospital, Mito

Jigenji Kubo Clinic, Kagoshima

Kawahara Hinyoukika, Kagoshima

Yagi Clinic, Kagoshima

Yokohama Shin-midori General Hospital, Yokohama

Kumamoto Rosai Hospital, Yatsushiro

Rakusai Newtown Hospital, Kyoto

Tohoku University Hospital, Sendai

Shinshu University Hospital, Matsumoto

Suzuki Urological Clinic, Nagano

Senbokufujii Hospital, Sakai

Nanri Urological Clinic, Saga

Kasukabe Chuo General Hospital, Kasukabe

Hamamatsu University School of Medicine University Hospital, Hamamatsu

Tokyo Women's Medical University Medical Center East, Arakawa City

Koganeibashi Sakura Clinic, Koganei

Kunitachi Sakura Hospital, Kunitachi

University of Yamanashi Hospital, Chūō

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY